Cargando…

Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy

Squamous cell carcinoma of the head and neck (SCCHN) accounts for 5–7% of all malignancies. About 60% of newly diagnosed SCCHN are detected as locally advanced disease. Chemoradiation is a standard option and response rate to it is variable. Recently, a genetic classification of SCCHN has been propo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perri, Francesco, Ionna, Franco, Muto, Paolo, Marzo, Massimiliano Di, Caponigro, Francesco, Longo, Francesco, Vittoria Scarpati, Giuseppina Della, Lorenzo, Giuseppe Di, Giuliano, Mario, Solla, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331692/ https://www.ncbi.nlm.nih.gov/pubmed/30652016 http://dx.doi.org/10.4155/fsoa-2018-0058

Ejemplares similares

Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
por: Longo, Francesco, et al.
Publicado: (2020)

Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
por: Perri, Francesco, et al.
Publicado: (2020)

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy
por: Perri, Francesco, et al.
Publicado: (2019)

Patients affected by squamous cell carcinoma of the head and neck: A population particularly prone to developing severe forms of COVID-19
por: Perri, Francesco, et al.
Publicado: (2021)

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
por: Perri, Francesco, et al.
Publicado: (2009)

Management of recurrent nasopharyngeal carcinoma: current perspectives
por: Perri, F, et al.
Publicado: (2019)

Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
por: Fasano, Morena, et al.
Publicado: (2021)

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review
por: Perri, Francesco, et al.
Publicado: (2022)

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies
por: Ionna, Franco, et al.
Publicado: (2021)

Metastatic HPV‐related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment
por: Perri, Francesco, et al.
Publicado: (2017)

Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review
por: Pisconti, Salvatore, et al.
Publicado: (2020)

Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer
por: Perri, Francesco, et al.
Publicado: (2016)

Surgical oncology of the head and neck district during COVID-19 pandemic
por: Salzano, Giovanni, et al.
Publicado: (2021)

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial
por: Caponigro, Francesco, et al.
Publicado: (2016)

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
por: Lazzari, Grazia, et al.
Publicado: (2017)

Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report
por: Lazzari, Grazia, et al.
Publicado: (2018)

Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer
por: Perri, Francesco, et al.
Publicado: (2023)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
por: Iannelli, Federica, et al.
Publicado: (2020)

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
por: Perri, Francesco, et al.
Publicado: (2015)

New Prognostic and Predictive Markers in Head and Neck Tumors
por: Cantile, Monica, et al.
Publicado: (2016)

The Art of Counseling in the Treatment of Head and Neck Cancer: Exploratory Investigation among Perceptions of Health Professionals in Southern Italy
por: Addeo, Raffaele, et al.
Publicado: (2022)

Setup uncertainties for inter-fractional head and neck cancer in radiotherapy
por: Park, Eun-Tae, et al.
Publicado: (2016)

A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group
por: De Felice, Francesca, et al.
Publicado: (2020)

Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
por: Alterio, Daniela, et al.
Publicado: (2020)

Transoral robotic surgery in head and neck district: a retrospective study on 67 patients treated in a single center
por: Ionna, Fraco, et al.
Publicado: (2020)

New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy
por: Guida, Agostino, et al.
Publicado: (2020)

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
por: Combs, Stephanie E, et al.
Publicado: (2007)

Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
por: Paliwal, Rajan, et al.
Publicado: (2012)

Oral lichen planus and other confounding factors in narrow band imaging (NBI) during routine inspection of oral cavity for early detection of oral squamous cell carcinoma: a retrospective pilot study
por: Guida, Agostino, et al.
Publicado: (2019)

Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group
por: Merlotti, Anna, et al.
Publicado: (2014)

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck
por: Choi, J. Isabelle, et al.
Publicado: (2019)

Evaluation of the Efficacy of Rotational Corrections for Standard-Fractionation Head and Neck Image-Guided Radiotherapy
por: Kung, Joseph S., et al.
Publicado: (2019)

Confounding factors in the assessment of oral mucositis in head and neck cancer
por: Lorini, Luigi, et al.
Publicado: (2022)

Radiotherapy and Systemic Therapies: Focus on Head and Neck Cancer
por: De Felice, Francesca, et al.
Publicado: (2023)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck
por: Juvkam, Inga Solgård, et al.
Publicado: (2022)

Radiotherapy in the Adjuvant and Advanced Setting of CSCC
por: Muto, Paolo, et al.
Publicado: (2021)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d3unp27snsu2jennfp0e70unlp